Weiqiang Lü

4.9k total citations · 2 hit papers
97 papers, 3.3k citations indexed

About

Weiqiang Lü is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Weiqiang Lü has authored 97 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 24 papers in Oncology and 16 papers in Pharmacology. Recurrent topics in Weiqiang Lü's work include Computational Drug Discovery Methods (15 papers), Peptidase Inhibition and Analysis (10 papers) and Biochemical and Molecular Research (9 papers). Weiqiang Lü is often cited by papers focused on Computational Drug Discovery Methods (15 papers), Peptidase Inhibition and Analysis (10 papers) and Biochemical and Molecular Research (9 papers). Weiqiang Lü collaborates with scholars based in China, United States and Israel. Weiqiang Lü's co-authors include Jin Huang, Feixiong Cheng, Yun Tang, Guixia Liu, Mingyao Liu, Weihua Li, Jing Jiang, Wei‐Xing Zhou, Chuang Liu and Honglin Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Weiqiang Lü

96 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference

2012 638 citations Feixiong Cheng, Jing Jiang et al. PLoS Computational Biology profile →
Target identification among known drugs by deep learning from heterogeneous networks

2020 257 citations Xiangxiang Zeng, Weiqiang Lü et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiqiang Lü China	31	2.1k	1.1k	400	351	329	97	3.3k
Oleg Ursu United States	23	2.4k 1.1×	1.2k 1.1×	453 1.1×	295 0.8×	360 1.1×	51	3.8k
Xiaofeng Liu China	19	1.8k 0.9×	1.0k 0.9×	374 0.9×	430 1.2×	207 0.6×	54	3.3k
Shuxing Zhang United States	35	2.8k 1.3×	824 0.7×	339 0.8×	271 0.8×	631 1.9×	87	4.2k
Rita Santos United Kingdom	7	2.3k 1.1×	1.3k 1.2×	252 0.6×	272 0.8×	252 0.8×	10	3.3k
Cristian Bologa United States	30	3.3k 1.6×	1.4k 1.3×	484 1.2×	435 1.2×	553 1.7×	88	5.8k
Anneli Karlsson Sweden	9	2.6k 1.2×	1.5k 1.4×	283 0.7×	345 1.0×	301 0.9×	14	3.8k
Melissa F. Adasme Germany	11	1.9k 0.9×	1.1k 1.0×	600 1.5×	369 1.1×	279 0.8×	12	3.6k
V. Joachim Haupt Germany	19	2.1k 1.0×	1.1k 1.0×	647 1.6×	381 1.1×	280 0.9×	23	3.6k
Daniel Martinez Molina Sweden	16	3.1k 1.4×	527 0.5×	395 1.0×	281 0.8×	605 1.8×	20	4.3k
Sheng Tian China	30	2.6k 1.2×	1.5k 1.3×	644 1.6×	382 1.1×	469 1.4×	88	4.3k

Countries citing papers authored by Weiqiang Lü

Since Specialization

Citations

This map shows the geographic impact of Weiqiang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiang Lü more than expected).

Fields of papers citing papers by Weiqiang Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiang Lü. The network helps show where Weiqiang Lü may publish in the future.

Co-authorship network of co-authors of Weiqiang Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiang Lü. A scholar is included among the top collaborators of Weiqiang Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiang Lü. Weiqiang Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhihao, Di Dai, Xiaoding Ma, et al.. (2025). Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nature Cancer. 6(4). 612–628. 16 indexed citations

Wang, Yijie, Ying Chen, Yueming Xu, et al.. (2025). Cryo-EM structure of an activated GPR4–Gs signaling complex. Nature Communications. 16(1). 605–605. 1 indexed citations

Wang, Xuanhao, et al.. (2024). Low-loss and broadband complementary dual-output electro-optic modulator based on thin-film lithium niobate. Chinese Optics Letters. 22(9). 92201–92201. 1 indexed citations

Yang, Xinyu, Qiansen Zhang, Yueming Xu, et al.. (2024). Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A2 receptors. Science China Life Sciences. 67(5). 986–995. 3 indexed citations

Ma, Hui, Ying Huang, Lu Tang, et al.. (2023). Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer. Biochemical Pharmacology. 218. 115868–115868. 7 indexed citations

Yang, Xixi, Zhangming Niu, Yuansheng Liu, et al.. (2022). Modality-DTA: Multimodality Fusion Strategy for Drug–Target Affinity Prediction. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 20(2). 1200–1210. 44 indexed citations

Jin, Yunyun, Qianqian Liu, Peng Chen, et al.. (2022). A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration. Cell Discovery. 8(1). 24–24. 29 indexed citations

Huang, Dan, Yumiao Zhao, Chan Zhang, et al.. (2022). Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia. Cell Death and Disease. 13(11). 1004–1004. 13 indexed citations

Liu, Xi, Qian Hu, Wanyan Wang, et al.. (2021). A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer. Biochemical Pharmacology. 188. 114583–114583. 8 indexed citations

10.

Liu, Chuang, Junfei Zhao, Weiqiang Lü, et al.. (2020). Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes. PLoS Computational Biology. 16(2). e1007701–e1007701. 38 indexed citations

11.

Jiang, Xingwu, Zhitao Liu, Longlong Hu, et al.. (2018). Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists. European Journal of Medicinal Chemistry. 158. 123–133. 11 indexed citations

12.

Shen, Qiancheng, Feixiong Cheng, Weiqiang Lü, et al.. (2016). Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes. The American Journal of Human Genetics. 100(1). 5–20. 73 indexed citations

13.

Chen, Yi‐Ming, Zhongyu Xu, Dang Wu, et al.. (2015). Luciferase Reporter Gene Assay on Human 5-HT Receptor: Which Response Element Should Be Chosen?. Scientific Reports. 5(1). 8060–8060. 12 indexed citations

14.

Lü, Weiqiang, Feixiong Cheng, Jing Jiang, et al.. (2015). FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach. Scientific Reports. 5(1). 8114–8114. 40 indexed citations

15.

Xiu, Yunji, Jia Feng, Weiqiang Lü, et al.. (2014). Identification of a novel cognate cytosolic Hsp70 gene (MnHsc70-2) from oriental river prawn Macrobrachium nipponense and comparison of its expressions with the first cognate Hsc70 (MnHsc70-1) under different stresses. Cell Stress and Chaperones. 19(6). 949–961. 9 indexed citations

16.

Wang, Jieqiong, Li Zhang, Guoliang Chen, et al.. (2014). Small molecule 1′-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway. Breast Cancer Research and Treatment. 148(2). 279–289. 29 indexed citations

17.

Zhao, Xue Zhi, Weiqiang Lü, Cheng Song, & Jin Huang. (2013). Detection of mammalian 5‐lipoxygenase activity using the fluorescent probe dihydrorhodamine 123. European Journal of Lipid Science and Technology. 116(2). 119–125. 1 indexed citations

18.

Lü, Weiqiang, Xue Zhi Zhao, Zhongyu Xu, et al.. (2013). Development of a new colorimetric assay for lipoxygenase activity. Analytical Biochemistry. 441(2). 162–168. 53 indexed citations

19.

Hu, Yuan, Weiqiang Lü, Liyan Wang, et al.. (2012). Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1). European Journal of Medicinal Chemistry. 62. 148–157. 30 indexed citations

20.

Wang, Liyan, Xi Li, Shoude Zhang, et al.. (2012). Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Bioorganic & Medicinal Chemistry. 20(13). 4164–4171. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact